The enrichment scores of the known biological processes, such as CD8 + T effectors, FGFR3-related genes and WNT targets, were different between the distinct TET2 expression groups (Fig. S9B), which suggested the potential pathway of action of TET2 in CRC. The gene discussed is CD8A; the disease is colorectal carcinoma.